US Bancorp’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
16,118
+3,037
+23% +$258K ﹤0.01% 1083
2026
Q1
$1.13M Buy
13,081
+170
+1% +$15.3K ﹤0.01% 1093
2025
Q4
$1.13M Sell
12,911
-374
-3% -$28.4K ﹤0.01% 1098
2025
Q3
$761K Buy
13,285
+806
+6% +$46.4K ﹤0.01% 1273
2025
Q2
$737K Buy
12,479
+8,183
+190% +$529K ﹤0.01% 1260
2025
Q1
$314K Sell
4,296
-9
-0.2% -$744 ﹤0.01% 1747
2024
Q4
$356K Buy
4,305
+135
+3% +$10.6K ﹤0.01% 1694
2024
Q3
$298K Sell
4,170
-145
-3% -$10.2K ﹤0.01% 1811
2024
Q2
$296K Buy
4,315
+355
+9% +$21.2K ﹤0.01% 1795
2024
Q1
$212K Sell
3,960
-275
-6% -$14.8K ﹤0.01% 1969
2023
Q4
$226K Sell
4,235
-607
-13% -$29.6K ﹤0.01% 1948
2023
Q3
$240K Buy
4,842
+32
+0.7% +$1.79K ﹤0.01% 1746
2023
Q2
$286K Sell
4,810
-3,638
-43% -$207K ﹤0.01% 1698
2023
Q1
$478K Sell
8,448
-3,046
-27% -$195K ﹤0.01% 1413
2022
Q4
$854K Buy
11,494
+1,418
+14% +$96.5K ﹤0.01% 1129
2022
Q3
$601K Sell
10,076
-190
-2% -$11.4K ﹤0.01% 1305
2022
Q2
$577K Buy
10,266
+1,971
+24% +$130K ﹤0.01% 1363
2022
Q1
$612K Buy
8,295
+103
+1% +$7.16K ﹤0.01% 1438
2021
Q4
$591K Buy
8,192
+207
+3% +$15K ﹤0.01% 1444
2021
Q3
$611K Buy
7,985
+116
+1% +$9.31K ﹤0.01% 1426
2021
Q2
$609K Sell
7,869
-553
-7% -$39.3K ﹤0.01% 1443
2021
Q1
$519K Buy
8,422
+694
+9% +$44K ﹤0.01% 1475
2020
Q4
$503K Sell
7,728
-1,119
-13% -$64.3K ﹤0.01% 1428
2020
Q3
$438K Sell
8,847
-364
-4% -$18.8K ﹤0.01% 1392
2020
Q2
$439K Buy
9,211
+229
+3% +$11K ﹤0.01% 1367
2020
Q1
$382K Buy
8,982
+1,222
+16% +$60.4K ﹤0.01% 1354
2019
Q4
$457K Sell
7,760
-323
-4% -$17.5K ﹤0.01% 1418
2019
Q3
$413K Buy
8,083
+3,280
+68% +$156K ﹤0.01% 1464
2019
Q2
$203K Sell
4,803
-2,528
-34% -$110K ﹤0.01% 1825
2019
Q1
$362K Sell
7,331
-810
-10% -$36.6K ﹤0.01% 1541
2018
Q4
$352K Sell
8,141
-2,238
-22% -$112K ﹤0.01% 1494
2018
Q3
$589K Sell
10,379
-472
-4% -$24.8K ﹤0.01% 1366
2018
Q2
$547K Sell
10,851
-1,756
-14% -$91.6K ﹤0.01% 1397
2018
Q1
$627K Sell
12,607
-16,514
-57% -$776K ﹤0.01% 1338
2017
Q4
$1.2M Sell
29,121
-9,850
-25% -$345K ﹤0.01% 1017
2017
Q3
$1.16M Buy
38,971
+587
+2% +$17.9K ﹤0.01% 1007
2017
Q2
$1.27M Sell
38,384
-3,551
-8% -$112K ﹤0.01% 956
2017
Q1
$1.24M Buy
41,935
+8,340
+25% +$228K ﹤0.01% 972
2016
Q4
$833K Sell
33,595
-5,716
-15% -$130K ﹤0.01% 1150
2016
Q3
$887K Sell
39,311
-2,864
-7% -$67.3K ﹤0.01% 1091
2016
Q2
$1M Buy
42,175
+1,304
+3% +$31.3K ﹤0.01% 1002
2016
Q1
$971K Sell
40,871
-2,202
-5% -$53.8K ﹤0.01% 990
2015
Q4
$1.2M Buy
43,073
+11,211
+35% +$281K ﹤0.01% 874
2015
Q3
$658K Buy
31,862
+15,248
+92% +$386K ﹤0.01% 1169
2015
Q2
$426K Buy
16,614
+11,005
+196% +$279K ﹤0.01% 1424
2015
Q1
$142K Buy
5,609
+427
+8% +$10.4K ﹤0.01% 1940
2014
Q4
$124K Sell
5,182
-623
-11% -$13.8K ﹤0.01% 2006
2014
Q3
$114K Sell
5,805
-1,331
-19% -$27.4K ﹤0.01% 2036
2014
Q2
$170K Sell
7,136
-484
-6% -$11.7K ﹤0.01% 1873
2014
Q1
$202K Buy
7,620
+2,278
+43% +$54.1K ﹤0.01% 1776
2013
Q4
$108K Buy
5,342
+3,612
+209% +$67K ﹤0.01% 2053
2013
Q3
$30K Buy
1,730
+170
+11% +$2.94K ﹤0.01% 2526
2013
Q2
$26K Buy
+1,560
New +$24.1K ﹤0.01% 2555

Other funds holding GMED

US Bancorp's GMED Position: Q2 2026 in Review

US Bancorp increased its Globus Medical (GMED) stake by 23% in Q2 2026, buying an estimated $258K and bringing the position to 16,118 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

US Bancorp first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • US Bancorp held 16,118 shares of Globus Medical worth $1.27M as of Q2 2026.
  • US Bancorp bought 3,037 Globus Medical shares in Q2 2026, an estimated $258K.
  • Globus Medical made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1083 holding.
  • US Bancorp first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.